文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

前列腺立体定向消融放疗毒性与生活质量的剂量学预测因素

Dosimetric predictors of toxicity and quality of life following prostate stereotactic ablative radiotherapy.
PubMed 文献 · Radiother Oncol · 2019-12-03

该研究汇总四项II期试验中258例临床局限性前列腺癌患者,处方剂量35-40 Gy分5次,中位随访6.1年。单因素分析中膀胱与直肠多个剂量参数可预测晚期毒性和生活质量临床重要改变,多因素分析仅膀胱V38、直肠Dmax、V38及膀胱D2cc等高风险剂量区参数保持显著。结论提示前列腺SABR后高剂量区比低剂量区更能预测晚期毒性和生活质量下降,应避免膀胱和直肠内的高剂量与热点。

要点

  • 高剂量区参数比低剂量区更能预测晚期毒性和生活质量改变
  • 多因素分析中膀胱V38与直肠Dmax、V38及膀胱D2cc为显著预测因素
  • 应谨慎避免膀胱和直肠内的高剂量与热点

核心结论

  • 前列腺SABR后膀胱和直肠的高剂量区较低剂量区更能预测晚期毒性和生活质量,应避免这些器官内的高剂量与热点。

研究设计与样本

  • 汇总分析四项II期试验,纳入258例前列腺癌患者,覆盖全部三个风险组,处方剂量35-40 Gy分5次,收集CTCAE毒性和EPIC生活质量及膀胱、直肠、阴茎球剂量参数,中位随访6.1年,采用单因素后多因素logistic回归分析。

主要发现

  • 单因素分析中膀胱Dmax、V38、D1cc、D2cc、D5cc及直肠V35可预测泌尿和肠道生活质量临床重要改变。
  • 多因素分析中仅膀胱V38仍为生活质量的显著预测因素。
  • 单因素分析中多个参数与晚期毒性显著相关,多因素分析中仅直肠Dmax、V38和膀胱D2cc为显著预测因素。

关键数值与推荐

  • 处方剂量35-40 Gy分5次。
  • 多因素分析显著预测因素:膀胱V38(生活质量);直肠Dmax、直肠V38、膀胱D2cc(晚期毒性)。

临床怎么用

  • 前列腺SABR计划评估时应重点关注膀胱和直肠的高剂量区参数,如膀胱V38、D2cc及直肠Dmax、V38,以降低晚期毒性和生活质量下降风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: SABR offers an effective treatment option for clinically localized prostate cancer. Here we report the dosimetric predictors of late toxicity and quality of life (QOL) in a pooled cohort of patients from four phase II trials. METHODS: The combined cohort included all three prostate cancer risk groups. The prescription dose was 35-40 Gy in 5 fractions. Toxicity (CTCAE) and QOL (EPIC) were collected. Multiple dosimetric parameters for the bladder, rectum and penile bulb were collected. Univariate (UVA) followed by multivariate (MVA) logistic regression analysis was conducted to search for significant dosimetric predictors of late GI/GU toxicity, or minimal clinically important change in the relevant QOL domain. RESULTS: 258 patients were included with median follow up of 6.1 years. For QOL, bladder Dmax, V38, D1cc, D2cc, D5cc and rectal V35 were predictors of urinary and bowel MCIC on UVA. On MVA, only bladder V38 remained significant. For late toxicity, various parameters were significant on UVA but only rectal Dmax, V38 and bladder D2cc were significant predictors on MVA. CONCLUSIONS: This report confirms that the high-dose regions in the bladder and rectum are more significant predictors of late toxicity and QOL after prostate SABR compared to low-dose regions. Caution must be taken to avoid high doses and hotspots in those organs.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Alayed Y, Davidson M, Quon H, et al. Dosimetric predictors of toxicity and quality of life following prostate stereotactic ablative radiotherapy. Radiother Oncol. 2019. PMID: 31809979. doi:10.1016/j.radonc.2019.11.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。